Open AccessThe Association Between Oral Contraceptives, Depot-Medroxyprogesterone Acetate, and Trichomoniasis
Author(s) -
Michelle Torok,
William C. Miller,
Marcia M. Hobbs,
Pia D. M. MacDonald,
Peter A. Leone,
Jane R. Schwebke,
Arlene C. Seña
Publication year - 2009
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/olq.0b013e318199723f
Subject(s) - trichomoniasis , medicine , hormonal contraception , gynecology , odds ratio , obstetrics , population , sexually transmitted disease , medroxyprogesterone acetate , condom , family planning , syphilis , estrogen , human immunodeficiency virus (hiv) , immunology , environmental health , research methodology
Hormonal contraception use by women may increase the risk of acquiring certain sexually transmitted infections. We explored the effect of hormonal contraceptive use, specifically oral contraception (OC), and depot-medroxyprogesterone acetate (DMPA) on Trichomonas vaginalis infections in women.